Form 4: Nuvalent CLO Sells Shares After Option Exercise

Nuvalent's Chief Legal Officer, Deborah Ann Miller, exercised stock options and subsequently sold 24,200 shares of Class A Common Stock for over $2.5 million, pursuant to a pre-arranged 10b5-1 trading plan.

Summary

• Deborah Ann Miller, Nuvalent, Inc.'s Chief Legal Officer, engaged in transactions involving the company's Class A Common Stock on November 17, 2025.
• Miller exercised stock options to acquire 24,200 shares at an exercise price of $6.89 per share.
• Immediately following the option exercise, Miller sold all 24,200 acquired shares in multiple open market transactions.
• The sales occurred at weighted average prices of $105.16 (15,075 shares), $105.98 (8,517 shares), and $107.04 (608 shares).
• The total proceeds from the sale of 24,200 shares amounted to approximately $2,553,177.38.
• All reported transactions were executed under a Rule 10b5-1 trading plan adopted by Miller on November 18, 2024.
• Following these transactions, Miller directly beneficially owns 49,086 shares of Class A Common Stock and 94,608 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic trading. The transaction represents a planned liquidity event for the executive, realizing significant gains from vested options.

Positives

• The Chief Legal Officer realized a significant profit by exercising options at a low price ($6.89) and selling shares at a substantially higher market price (average over $105).
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, non-public information.

Negatives

• A high-ranking insider selling a substantial number of shares (24,200 shares) could be perceived negatively by some investors, despite the existence of a 10b5-1 plan.

Risks

• The market's perception of insider selling, even when pre-planned, could lead to short-term negative sentiment or downward pressure on the stock price.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, such as option exercises and subsequent share sales, are common events in publicly traded companies. While often pre-planned through 10b5-1 plans to avoid accusations of trading on material non-public information, they are closely watched by investors as potential signals regarding management's confidence or personal financial planning.

Corporate Governance

Stakeholder Impact

• Shareholders: May react to the insider selling, potentially leading to short-term stock price volatility, although the 10b5-1 plan provides context.
• Employees: No direct impact mentioned, but general sentiment around executive actions can influence morale.

Key Dates

Recommendation

This Form 4 filing details a pre-planned insider transaction (option exercise and sale) by a Chief Legal Officer. While the sale of a significant number of shares by an executive can sometimes be a negative signal, the execution under a Rule 10b5-1 plan suggests a planned liquidity event rather than a reaction to new, adverse company information. As such, this filing alone does not provide sufficient new fundamental information to warrant a change in a long-term investment thesis. Investors should continue to monitor broader company performance and market conditions.

Keywords

Nuvalent, NUVL, Insider Trading, Form 4, Stock Options, Share Sale, Deborah Ann Miller, Chief Legal Officer, 10b5-1 Plan